These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 26046589)

  • 61. Acquired hemophilia A following generalized pustular psoriasis of pregnancy.
    Iinuma S; Minami-Hori M; Honma M; Ishida-Yamamoto A
    J Dermatol; 2017 Dec; 44(12):e324-e325. PubMed ID: 28771773
    [No Abstract]   [Full Text] [Related]  

  • 62. [Therapeutic management of psoriasis].
    Guilhou JJ
    Ann Dermatol Venereol; 1996; 123(4):276-9. PubMed ID: 8763756
    [No Abstract]   [Full Text] [Related]  

  • 63. Life-threatening pustular and erythrodermic psoriasis responding to infliximab.
    Lewis TG; Tuchinda C; Lim HW; Wong HK
    J Drugs Dermatol; 2006 Jun; 5(6):546-8. PubMed ID: 16774108
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Current systemic therapies for psoriasis: where are we now?
    Yamauchi PS; Rizk D; Kormeili T; Patnaik R; Lowe NJ
    J Am Acad Dermatol; 2003 Aug; 49(2 Suppl):S66-77. PubMed ID: 12894129
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Generalized pustular psoriasis of pregnancy treated with oral cyclosporin.
    Kura MM; Surjushe AU
    Indian J Dermatol Venereol Leprol; 2006; 72(6):458-9. PubMed ID: 17179628
    [No Abstract]   [Full Text] [Related]  

  • 66. [The treatment of psoriasis].
    Lauharanta J
    Duodecim; 1993; 109(5):441-7. PubMed ID: 8020412
    [No Abstract]   [Full Text] [Related]  

  • 67. Clinical profile, morbidity, and outcome of adult-onset generalized pustular psoriasis: analysis of 102 cases seen in a tertiary hospital in Johor, Malaysia.
    Choon SE; Lai NM; Mohammad NA; Nanu NM; Tey KE; Chew SF
    Int J Dermatol; 2014 Jun; 53(6):676-84. PubMed ID: 23967807
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Acute Generalized Pustular Psoriasis Treated With the IL-17A Antibody Secukinumab.
    Böhner A; Roenneberg S; Eyerich K; Eberlein B; Biedermann T
    JAMA Dermatol; 2016 Apr; 152(4):482-4. PubMed ID: 26650014
    [No Abstract]   [Full Text] [Related]  

  • 69. Treatment of pustular psoriasis with infliximab.
    Weishaupt C; Metze D; Luger TA; Ständer S
    J Dtsch Dermatol Ges; 2007 May; 5(5):397-9. PubMed ID: 17451384
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Ustekinumab treats psoriasis refractory to seven conventional and biologic therapies.
    Rallis E; Verros CD
    Dermatol Online J; 2011 Apr; 17(4):14. PubMed ID: 21549089
    [No Abstract]   [Full Text] [Related]  

  • 71. Traditional systemic treatments have not fully met the needs of psoriasis patients: results from a national survey.
    Nijsten T; Margolis DJ; Feldman SR; Rolstad T; Stern RS
    J Am Acad Dermatol; 2005 Mar; 52(3 Pt 1):434-44. PubMed ID: 15761421
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Additive effects of calcipotriol and cyclosporine A: from in vitro experiments to in vivo applications in the treatment of severe psoriasis.
    Bagot M; Grossman R; Pamphile R; Binderup L; Charue D; Revuz J; Dubertret L
    C R Acad Sci III; 1994 Mar; 317(3):282-6. PubMed ID: 7994616
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Advances in psoriasis therapy.
    Koo J; Nguyen Q; Gambla C
    Adv Dermatol; 1997; 12():47-72; discussion 73. PubMed ID: 8973735
    [No Abstract]   [Full Text] [Related]  

  • 74. Vitamin D and systemic therapy.
    van de Kerkhof P
    Cutis; 2002 Nov; 70(5 Suppl):16-20. PubMed ID: 12467335
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Successful treatment with infliximab of sibling cases with generalized pustular psoriasis caused by deficiency of interleukin-36 receptor antagonist.
    Sugiura K; Endo K; Akasaka T; Akiyama M
    J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):2054-6. PubMed ID: 24910924
    [No Abstract]   [Full Text] [Related]  

  • 76. Long-term efficacy of psoriasis vulgaris treatments: analysis of treatment with topical corticosteroid and/or vitamin D3 analog, oral cyclosporin, etretinate and phototherapy over a 35-year period, 1975-2010.
    Akasaka E; Mabuchi T; Manabe Y; Yahagi E; Yamada-Hiruma A; Yamaoka H; Kojima T; Kato M; Ikoma N; Ozawa A; Haruki Y
    J Dermatol; 2013 Apr; 40(4):238-43. PubMed ID: 23330814
    [TBL] [Abstract][Full Text] [Related]  

  • 77. How are we using systemic drugs to treat psoriasis in children? An insight into current clinical U.K. practice.
    Burden-Teh E; Lam ML; Taibjee SM; Taylor A; Webster S; Dolman S; Jury C; Caruana D; Darne S; Carmichael A; Natarajan S; McPherson T; Moore A; Katugampola R; Kalavala M; Al-Ismail D; Richards L; Jones V; Batul Syed S; Glover M; Hughes J; Anderson E; Hughes B; Helbling I; Murphy R
    Br J Dermatol; 2015 Aug; 173(2):614-8. PubMed ID: 25601323
    [No Abstract]   [Full Text] [Related]  

  • 78. Biologic therapy in erythrodermic and pustular psoriasis.
    Levin EC; Debbaneh M; Koo J; Liao W
    J Drugs Dermatol; 2014 Mar; 13(3):342-54. PubMed ID: 24595581
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Eosinophils, pruritus and psoriasis: effects of treatment with etretinate or cyclosporin-A.
    Schopf RE; Hultsch T; Lotz J; Bräutigam M
    J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):234-9. PubMed ID: 9883435
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Nail psoriasis: a retrospective study on the effectiveness of systemic treatments (classical and biological therapy).
    Sánchez-Regaña M; Sola-Ortigosa J; Alsina-Gibert M; Vidal-Fernández M; Umbert-Millet P
    J Eur Acad Dermatol Venereol; 2011 May; 25(5):579-86. PubMed ID: 21198950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.